Geriatric Depression Treatment in Nonresponders to Selective Serotonin Reuptake Inhibitors
The DOI matches its Crossref record.
Abstract
BACKGROUND: Up to a third of elderly patients with major depressive disorder are treatment resistant, yet little objective evidence is available to guide the clinician in managing these patients. We report here our experience with elderly subjects with prospectively defined treatment-resistant depression in 2 separate research studies: one entailing an augmentation strategy, the other a change to venlafaxine extended release (XR). METHOD: Fifty-three elderly subjects with major depressive disorder according to DSM-IV criteria who failed treatment with paroxetine plus interpersonal psychotherapy received 1 to 3 trials of augmentation with bupropion sustained release, nortriptyline, or lithium. Successively fewer subjects entered each sequential trial of augmentation. Twelve subjects subsequently received venlafaxine XR monotherapy. Response to treatment was defined as a 17-item Hamilton Rating Scale for Depression score of < 10 for 3 weeks. RESULTS: Sixty percent of subjects (N = 32) responded to some form of augmentation, with 45% (24/53), 31% (5/16), and 43% (3/7) responding to the first, second, and third augmentation trials, respectively. The mean time to response after starting the first augmentation trial was 6.0 (SD = 5.8) weeks. Forty-two percent (N = 5) of the venlafaxine XR-treated subjects responded with the mean time to response of 6.4 (SE = 0.9) weeks. Adverse effects leading to treatment discontinuation and falls were more common in the augmentation subjects than in the venlafaxine XR subjects. CONCLUSION: We observed similar rates and speed of response with an augmentation strategy and a strategy of switching to venlafaxine XR in elderly subjects with prospectively defined treatment-resistant major depressive disorder. Venlafaxine XR was generally better tolerated than the augmentation strategies. Further investigation of venlafaxine XR as a preferred strategy for treatment-resistant geriatric depression is warranted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This may be due to a greater number of depressive episodes, which is associated with the depletion of neural248, interpersonal249,250 and psychosocial resources249,250.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [248]
In the citing paper
“This may be due to a greater number of depressive episodes, which is associated with the depletion of neural248, interpersonal249,250 and psychosocial resources249,250.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [248]
Citations
Cites
Still being checked.
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Maintenance Treatment of Major Depression in Old Age
Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052619 · Cited by 476
Self-citationPsychobiological factors of resilience and depression in late life
Laird, K. T., Krause, B., Funes, C., & Lavretsky, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0424-7 · Cited by 229
A Systematic Review of Treatments for Refractory Depression in Older People
Cooper, C., Katona, C., Lyketsos, K., Blazer, D., Brodaty, H., Rabins, P., de Mendonça Lima, C. A., & Livingston, G. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10081165 · Cited by 176
Kaster, T. S., Daskalakis, Z. J., Noda, Y., Knyahnytska, Y., Downar, J., Rajji, T. K., Levkovitz, Y., Zangen, A., Butters, M. A., Mulsant, B. H., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0121-x · Cited by 174
Self-citationResidual symptoms and recurrence during maintenance treatment of late-life depression
Dombrovski, A. Y., Mulsant, B. H., Houck, P. R., Mazumdar, S., Lenze, E. J., Andreescu, C., Cyranowski, J. M., & Reynolds, C. F. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.020 · Cited by 173
Self-citationUse of Bupropion in Combination with Serotonin Reuptake Inhibitors
Zisook, S., Rush, A. J., Haight, B. R., Clines, D. C., & Rockett, C. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.027 · Cited by 173
Cardiovascular Changes Associated With Venlafaxine in the Treatment of Late-Life Depression
Johnson, E. M., Whyte, E. M., Mulsant, B. H., Pollock, B. G., Weber, E., Begley, A. E., & Reynolds, C. F. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000204328.50105.b3 · Cited by 130
Self-citationDew, M. A., Whyte, E. M., Lenze, E. J., Houck, P. R., Mulsant, B. H., Pollock, B. G., Stack, J. A., Bensasi, S., & Reynolds, C. F. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.892 · Cited by 124
Self-citationBlumberger, D. M., Mulsant, B. H., Fitzgerald, P. B., Rajji, T. K., Ravindran, A. V., Young, L. T., Levinson, A. J., & Daskalakis, Z. J. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.579163 · Cited by 118
Self-citationAging and Clinical Pharmacology: Implications for Antidepressants
Lotrich, F. E., & Pollock, B. G. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005280297 · Cited by 108
Anterior cingulate cortical volumes and treatment remission of geriatric depression
Gunning, F. M., Cheng, J., Murphy, C. F., Kanellopoulos, D., Acuna, J., Hoptman, M. J., Klimstra, S., Morimoto, S., Weinberg, J., & Alexopoulos, G. S. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2290 · Cited by 107
A Systematic Approach to Pharmacotherapy for Geriatric Major Depression
Mulsant, B. H., Blumberger, D. M., Ismail, Z., Rabheru, K., & Rapoport, M. J. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.05.002 · Cited by 99
Self-citationAlexopoulos, G. S., Canuso, C. M., Gharabawi, G. M., Bossie, C. A., Greenspan, A. J., Turkoz, I., & Reynolds, C. F. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31813546f2 · Cited by 101
Self-citationMedical Burden in Late-Life Bipolar and Major Depressive Disorders
Gildengers, A. G., Whyte, E. M., Drayer, R. A., Soreca, I., Fagiolini, A. M., Kilbourne, A. M., Houck, P. R., Reynolds, C. F., Frank, E., Kupfer, D. J., et al. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318157c5b1 · Cited by 103
Self-citationEmpirically Derived Decision Trees for the Treatment of Late-Life Depression
Andreescu, C., Mulsant, B. H., Houck, P. R., Whyte, E. M., Mazumdar, S., Dombrovski, A. Y., Pollock, B. G., & Reynolds, C. F. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07081340 · Cited by 82
Self-citationIncomplete response in late-life depression: getting to remission
Lenze, E. J., Sheffrin, M., Driscoll, H. C., Mulsant, B. H., Pollock, B. G., Amanda Dew, M., Lotrich, F., Devlin, B., Bies, R., & Reynolds III, C. F. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/jlenze · Cited by 79
Self-citationCaldiroli, A., Capuzzi, E., Tagliabue, I., Capellazzi, M., Marcatili, M., Mucci, F., Colmegna, F., Clerici, M., Buoli, M., & Dakanalis, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313070 · Cited by 70
Treatment-resistant Late-life Depression: Challenges and Perspectives
Knochel, C., Alves, G., Friedrichs, B., Schneider, B., Schmidt-Rechau, A., Wenzler, S., Schneider, A., Prvulovic, D., F. Carvalho, A., & Oertel-Knochel, V. (2015) · Current Neuropharmacology · doi:10.2174/1570159x1305151013200032 · Cited by 69
Dombrovski, A. Y., Lenze, E. J., Dew, M. A., Mulsant, B. H., Pollock, B. G., Houck, P. R., & Reynolds, C. F. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01292.x · Cited by 61
Self-citationLate-onset major depression: clinical and treatment-response variability
Driscoll, H. C., Basinski, J., Mulsant, B. H., Butters, M. A., Dew, M. A., Houck, P. R., Mazumdar, S., Miller, M. D., Pollock, B. G., Stack, J. A., et al. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1334 · Cited by 57
Self-citationDynamic Prediction of Treatment Response in Late-Life Depression
Joel, I., Begley, A. E., Mulsant, B. H., Lenze, E. J., Mazumdar, S., Dew, M. A., Blumberger, D., Butters, M., & Reynolds, C. F. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.07.002 · Cited by 55
Self-citationCristancho, P., Lenard, E., Lenze, E. J., Miller, J. P., Brown, P. J., Roose, S. P., Montes-Garcia, C., Blumberger, D. M., Mulsant, B. H., Lavretsky, H., et al. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.04.005 · Cited by 54
Self-citationMarshe, V. S., Maciukiewicz, M., Rej, S., Tiwari, A. K., Sibille, E., Blumberger, D. M., Karp, J. F., Lenze, E. J., Reynolds, C. F., Kennedy, J. L., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050617 · Cited by 54
Self-citationBaba, H., Kito, S., Nukariya, K., Takeshima, M., Fujise, N., Iga, J., Oshibuchi, H., Kawano, M., Kimura, M., Mizukami, K., et al. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13349 · Cited by 50
Treatment of Depression in Older Adults
Bottino, C. M. C., Barcelos‐Ferreira, R., & Ribeiz, S. R. I. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0281-z · Cited by 55
Use of Antidepressants in Late-Life Depression
Rajji, T. K., Mulsant, B. H., Lotrich, F. E., Lokker, C., & Reynolds, C. F. (2008) · Drugs & Aging · doi:10.2165/00002512-200825100-00003 · Cited by 52
Self-citationLEUCHTER, A. F., LESSER, I. M., TRIVEDI, M. H., RUSH, A. J., MORRIS, D. W., WARDEN, D., FAVA, M., WISNIEWSKI, S. R., LUTHER, J. F., PERALES, M., et al. (2008) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000336754.19566.65 · Cited by 45
CYP2D6 genotype and venlafaxine‐XR concentrations in depressed elderly
Whyte, E. M., Romkes, M., Mulsant, B. H., Kirshne, M. A., Begley, A. E., Reynolds, C. F., & Pollock, B. G. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1522 · Cited by 45
Self-citationMarshe, V. S., Maciukiewicz, M., Hauschild, A.-C., Islam, F., Li, Q., Tiwari, A. K., Sibille, E. L., Blumberger, D. M., Karp, J. F., Flint, A. J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01248-3 · Cited by 45
Self-citationShea, M. L. O., Garfield, L. D., Teitelbaum, S. L., Civitelli, R., Mulsant, B. H., Reynolds, C. F., Dixon, D. J., Doré, P., & Lenze, E. J. (2013) · Osteoporosis International · doi:10.1007/s00198-012-2170-z · Cited by 48
Self-citationMarshe, V. S., Islam, F., Maciukiewicz, M., Bousman, C., Eyre, H. A., Lavretsky, H., Mulsant, B. H., Reynolds, C. F., Lenze, E. J., & Müller, D. J. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.01.007 · Cited by 42
Self-citationOutcome of late‐life depression after 3 years of sequential treatment
Kok, R. M., Nolen, W. A., & Heeren, T. J. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01295.x · Cited by 38
Driscoll, H. C., Karp, J. F., Dew, M. A., & Reynolds, C. F. (2007) · Drugs & Aging · doi:10.2165/00002512-200724100-00002 · Cited by 38
Self-citationFakhoury, T. A., Miller, J. M., Hammer, A. E., & Vuong, A. (2008) · Drugs & Aging · doi:10.2165/0002512-200825110-00006 · Cited by 34
Impact of Prior Treatment Exposure on Response to Antidepressant Treatment in Late Life
Tew, J. D., Mulsant, B. H., Houck, P. R., Lenze, E. J., Whyte, E. M., Miller, M. D., STACK, J. A., Bensasi, S., & Reynolds, C. F. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000222311.70424.85 · Cited by 32
Self-citationKhundakar, A. A., Morris, C. M., Oakley, A. E., & Thomas, A. J. (2011) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2011.04.008 · Cited by 29
Maust, D. T., Oslin, D. W., & Thase, M. E. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.030 · Cited by 25
Maust, D. T., Oslin, D. W., & Thase, M. E. (2012) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31826576cf · Cited by 22
Addressing Both Depression and Pain in Late Life: The Methodology of the ADAPT Study
Karp, J. F., Rollman, B. L., Reynolds, C. F., Morse, J. Q., Lotrich, F., Mazumdar, S., Morone, N. E., & Weiner, D. K. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01322.x · Cited by 22
Self-citationAntidepressant utilization in primary care in a Spanish region
Úbeda, A., Cardo, E., Sellés, N., Solaz, R. B., Trillo-Mata, J. L., & Fernández-Llimós, F. (2007) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-006-0149-9 · Cited by 20
Marshe, V. S., Islam, F., Maciukiewicz, M., Fiori, L. M., Yerko, V., Yang, J., Turecki, G., Foster, J. A., Kennedy, S. H., Blumberger, D. M., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109867 · Cited by 20
Self-citationCellular Morphometry in Late-Life Depression: A Review of Postmortem Studies
Khundakar, A. A., & Thomas, A. J. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.06.003 · Cited by 16
van den Broek, W. W., Mulder, P., van Os, E., Birkenhäger, T., Pluijms, E. M., & Bruijn, J. A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089821 · Cited by 19
Antidepressant Pharmacogenetics
Singh, A., & Bousman, C. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17020173 · Cited by 14
Karp, J. F., & Reynolds, C. F. (2009) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.7.1.foc17 · Cited by 16
Self-citationBhattacharjee, S., Lee, J. K., Patanwala, A. E., Vadiei, N., Malone, D. C., Knapp, S. M., Lo-Ciganic, W.-H., & Burke, W. J. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.02.002 · Cited by 15
Design and analysis of trials of combination therapies.
Hosking, J. D., Cisler, R. A., Couper, D. J., Gastfriend, D. R., Kivlahan, D. R., & Anton, R. F. (2005) · Journal of Studies on Alcohol Supplement · doi:10.15288/jsas.2005.s15.34 · Cited by 12
Buettner, L. L., Fitzsimmons, S., & Dudley, W. N. (2010) · Research in Gerontological Nursing · doi:10.3928/19404921-20100601-02 · Cited by 12
Bupropion-associated movement disorders: A systematic review
Rissardo, J. P., & Caprara, A. L. F. (2020) · Annals of Movement Disorders · doi:10.4103/aomd.aomd_35_19 · Cited by 14
Efficacy of Bupropion XR in Treatment-Resistant Elderly Patients: A Case Series Study
Bergman, J., Miodownik, C., Palatnik, A., & Lerner, V. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182096f5a · Cited by 9
Parmar, L., Morgan, L. D., & Patel, B. A. (2011) · Analytical Methods · doi:10.1039/c1ay05520h · Cited by 8
Treatment-Resistant Depression in the Elderly: Diagnostic and Treatment Approaches
Newman, B. M. (2016) · Current Geriatrics Reports · doi:10.1007/s13670-016-0186-5 · Cited by 11
Pharmacotherapy of Late-Life Depression: Evidence-Based Recommendations
Ellison, J. M., Sivrioglu, E. Y., & Salzman, C. (2008) · Medical psychiatry · doi:10.3109/9781420053302.015 · Cited by 5
A Review of Therapeutics for Treatment-Resistant Depression in the Older Adult
Blaszczyk, A. T., Mathys, M. L., & Le, J. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01051-3 · Cited by 9
Desmidt, T., & Camus, V. (2011) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(11)55039-4 · Cited by 4
Lenze, E. J., Karp, J. F., Gebara, M. A., Nicol, G. E., & Mulsant, B. H. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02338-w · Cited by 7
Self-citationRecognition and Treatment of Late-LifeDepression
Ellison, J. M., & Ujkaj, M. (2009) · Medical psychiatry · doi:10.3109/9781420084887.015 · Cited by 3
Adverse Effects of Pharmacological Treatments of Major Depression in Older Adults
Sobieraj, D. M. (2019) · doi:10.23970/ahrqepccer215 · Cited by 4
Trajectories of late-life depression: insights from molecular imaging
Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2
Advances in the Treatment of Geriatric Depression
Siamouli, M., Magiria, S., Panagiotidis, P., Spyridi, S., Sokolaki, S., Fountoulakis, K. Ν., & Kaprinis, G. (2007) · Aging Health · doi:10.2217/1745509x.3.4.495 · Cited by 2
Empirically Derived Decision Trees for the Treatment of Late-Life Depression
Andreescu, C., Mulsant, B. H., Houck, P. R., Whyte, E. M., Mazumdar, S., Dombrovski, A. Y., Pollock, B. G., & Reynolds, C. F. (2009) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.7.1.foc79 · Cited by 2
Self-citationCall to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults
Amodeo, K., Schneider, R. B., & Richard, I. H. (2016) · Geriatrics · doi:10.3390/geriatrics1040033 · Cited by 2
Depressive Disorders in the Elderly: A Review
Chiu, E., Ames, D. J., Draper, B., & Snowdon, J. A. (2009) · Wiley eBooks · doi:10.1002/9780470745892.ch5 · Cited by 8
Late-Life Depression Treatment: the State of the Art
Сафарова, Т. П. (2020) · Psikhiatriya · doi:10.30629/2618-6667-2020-18-3-95-107 · Cited by 1
Chapter 20. Psychopharmacology
Mulsant, B. H., & Pollock, B. G. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds20 · Cited by 1
Self-citationPharmacotherapy for the Treatment of Major Depressive Disorder in Late Life—A Narrative Review
Mulsant, B. H., & Lenze, E. J. (2026) · Psychiatric Annals · doi:10.3928/00485713-20260701-02 · Cited by 1
Self-citationAltamura, A. C., Cattaneo, E. F., Pozzoli, S. M., Bassetti, R., & Sacco, L. (2006) · Cited by 1
Introduction: Selecting an Antidepressant
Zimmerman, M. A. (2009) · CNS Spectrums · doi:10.1017/s1092852900026341 · Cited by 1
Use of Adjunctive Therapy in Older Depressed Adults Who are Resistant to Antidepressant Treatment
Nelson, J. C. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199796816.003.0021 · Cited by 1
Polypharmazie in der Gerontopsychiatrie
Ibach, B. (2009) · Springer eBooks · doi:10.1007/978-3-211-79826-3_6 · Cited by 4
Polypharmazie in der Gerontopsychiatrie
Ibach, B. (2006) · Springer eBooks · doi:10.1007/3-211-31221-8_6 · Cited by 1
Psychopharmaka in Geriatrie und Gerontopsychiatrie
Förstl, H., Lautenschlager, M. M., Lautenschlager, N. T., & Laux, G. (2010) · Springer eBooks · doi:10.1007/978-3-211-85473-0_17 · Cited by 1
Special populations: Treatment resistant mood disorders
Guinta, G. M., & Graham, R. L. (2014) · Mental Health Clinician · doi:10.9740/mhc.n207186
A Systematic Review of Treatments for Refractory Depression in Older People
Cooper, C., Katona, C., Lyketsos, K. G., Blazer, D. G., Brodaty, H., Rabins, P. V., Lima, C. A. D. M., & Livingston, G. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.87
Ângelo, V., Galhardo, C., Mariosa, M. A. S., & Takata, J. P. I. (2010)
Current awareness in geriatric psychiatry
Gillies, B. (1994) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930090415
Kmiec, J. A., Gildengers, A. G., Young, R. C., & Reynolds, C. F. (2008) · Medical psychiatry · doi:10.3109/9781420053302.019
Self-citationDepressive Disorders and Bipolar and Related Disorders
Tampi, R. R., Tampi, D. J., Walters, M. I., Manikkara, G., Alag, P., & Garg, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-73078-3_17
Current awareness in geriatric psychiatry
(2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1227
Current awareness in human psychopharmacology
(2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.636
Ibach, B. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1849-8_6
Flint, A. J. (2006) · International Psychogeriatrics · doi:10.1017/s1041610206254383
Persistence is the key to treating nonpsychotic major depressive disorder in elderly patients
&NA; (2008) · Drugs & Therapy Perspectives · doi:10.2165/00042310-200824050-00005
Therapieresistenz aus gerontopsychiatrischer Perspektive
Gutzmann, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65734-8_28
Tampi, R. R., & Tampi, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_9
Metadata
- Authors
- Whyte, E. M., Basinski, J., Farhi, P., Dew, M. A., Begley, A., Mulsant, B. H., & Reynolds, C. F.
- Affiliations
- University of Pittsburgh (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2004-12-15
- Volume
- 65
- Issue
- 12
- Pages
- 1634-1641
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2050851690
- Cited by
- 86
- References
- 0
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 6 · 2012: 3
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-52247, P30MH052247, MH-37869, MH-069430, MH-43832, K23MH067710, K24MH069430, R01MH037869, MH067710, T32MH019986)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- geriatric depression, treatment-resistant depression, major depressive disorder, elderly patients, selective serotonin reuptake inhibitors, paroxetine, interpersonal psychotherapy, augmentation therapy, bupropion, nortriptyline, lithium, venlafaxine extended release, adverse effects, falls
- MeSH terms
- Venlafaxine Hydrochloride, Aged, Aged, 80 and over, Antidepressive Agents, Tricyclic, Combined Modality Therapy, Cyclohexanols, Delayed-Action Preparations, Major Depressive Disorder, Drug Therapy, Combination, Female, Humans, Lithium, Male, Nortriptyline, Psychiatric Status Rating Scales, Psychotherapy, Geriatric Assessment, Bupropion, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Paroxetine, Antidepressive Agents, Second-Generation, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.